Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.

Slides:

Advertisements

Similar presentations

Supplementary Fig. 1. PD transport parameters in C57 mice.

Advertisements

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)

Volume 84, Issue 5, Pages (November 2013)

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Use of icodextrin in high transport ultrafiltration failure

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Volume 53, Issue 4, Pages (April 1998)

Volume 59, Issue 1, Pages (January 2001)

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury D.P. Gabriel, J.T. Caramori,

Volume 78, Issue 6, Pages (September 2010)

V. La Milia, M. Limardo, G. Virga, M. Crepaldi, F. Locatelli

Volume 68, Issue 2, Pages (August 2005)

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Volume 68, Issue 3, Pages (September 2005)

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.

PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:

Volume 60, Issue 6, Pages (December 2001)

The role of daily dialysis in the control of hyperphosphatemia

Profiling of peritoneal ultrafiltration

Vitamin K2 supplementation reduces dp-ucMGP but not dp-cMGP levels in dialysis patients. Vitamin K2 supplementation reduces dp-ucMGP but not dp-cMGP levels.

Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.

Association of HD treatment with polysomnographic parameters and EDS after adjustment for age, gender, and BMI. Error horizontal lines represent the 95%

Quantification of free water transport in peritoneal dialysis

(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E

Review of clinical trial experience with icodextrin

Volume 73, Issue 6, Pages (March 2008)

Correlation between the difference in overnight pKt/V (A) or pCrCl (B) and the change in AHI following conversion from NPD to CAPD. pKt/V, peritoneal Kt/V;

Mean and median systolic and diastolic BPs after dialysis were unchanged over time and similar between epoetin alfa-epbx and epoetin alfa. Mean and median.

Suggested treatment algorithm for resistant lupus nephritis

Ionized-to-total magnesium (Mg) and calcium (Ca) ratios are lower in patients on hemodialysis than those in patients not on dialysis. Ionized-to-total.

Volume 65, Issue 1, Pages (January 2004)

Mean plasma concentrations of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis (duration depicted by box.

Dialyzer clearance of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis. Dialyzer clearance of ampicillin/sulbactam.

Ca2+ infusion rates during all three protocol versions.

Volume 65, Issue 5, Pages (May 2004)

Volume 58, Issue 5, Pages (November 2000)

A loading dose decreases the time to achieve the target concentration.

Volume 58, Issue 4, Pages (October 2000)

Volume 57, Issue 4, Pages (April 2000)

Clinical characteristics and laboratory parameters in relation to dose of oral sodium bicarbonate. Clinical characteristics and laboratory parameters in.

Potential links between the immune dysfunction in uremia, inflammation, infection, and increased risk of atherosclerosis and cardiovascular disease. Potential.

Rates of plasma sodium concentration increase before and after DDAVP administration. Rates of plasma sodium concentration increase before and after DDAVP.

Graph showing percentage of total patients with PTD or IGT that would be detected in each category of FBG if an oral glucose tolerance test were performed.

Six-month change in proteinuria predicts risk for ESRD

Distribution of vascular access type (2002–2011) among countries with stable or decreasing catheter burden over time. Distribution of vascular access type.

Mortality caused by cardiovascular disease (A) and sepsis (B) of patients with end-stage renal disease (ESRD) treated by dialysis compared with the general.

(Left) Relationship between plasma urea and age (top; y = x ; r = 0

Comparison of Medicare reimbursement to a nephrology practice on an annual per-patient basis for care of a patient on dialysis (at two different frequencies.

Relationship between excess fluid, as determined by the difference between measured and estimated body water, and plasma albumin (R = −0.40, P = 0.011).

Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.

Gentamicin plasma and peritoneal dialysate concentrations in peritoneal dialysis patients with peritonitis. Gentamicin plasma and peritoneal dialysate.

Distribution of percent consistent facility aspirin use.

Changes in 44-hour interdialytic systolic BP as a function of change in echocardiographic volume parameter. Changes in 44-hour interdialytic systolic BP.

The Centers for Medicare and Medicaid Services (CMS) and the Kidney Care Quality Alliance (KCQA) ultrafiltration (UF) rate measure specifications and selection.

New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.

Per dialysis treatment funding and facility/network staff ratio by ESRD Network. Per dialysis treatment funding and facility/network staff ratio by ESRD.

Causal diagrams that represent three possible relationships between smoking, ESRD, and albumin-to-creatinine ratio (ACR) in the Study of Heart and Renal.

Renal replacement therapy using an in-line hemofilter during extracorporeal membrane oxygenation (ECMO). Renal replacement therapy using an in-line hemofilter.

Distribution of SDS for serum creatinine, serum BUN, SBP, and DBP per quintiles of KS. Quintiles are expressed in SDS (see Figure 1B): 1st quintile,

Effect of intervention differed across racial and socioeconomic groups

As the patient nears the end of life (dashed arrow), there is an increasing focus on symptom control and patient goals of care and a shift in the approach.

Plasma concentration-time profile after oral administration of a single dose. Plasma concentration-time profile after oral administration of a single dose.

Renal replacement therapy (RRT) using RRT machine during extracorporeal membrane oxygenation (ECMO). Renal replacement therapy (RRT) using RRT machine.

Receiver operator characteristic (ROC) curve for fasting blood glucose (FBG) predicting posttransplantation diabetes (PTD) using time 0 FBG (a) and screening.

Plateau 13C-ketoisocaproic acid (KIC) enrichment during whole-body protein turnover (WBPT) study. 13C-KIC values (mean ± SD) in 12 patients in moles percent.

Distribution of facility mean treatment time, by DOPPS region and phase. Distribution of facility mean treatment time, by DOPPS region and phase. Restricted.

Presentation transcript:

Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. (A) 4-hour dialysate to plasma ratio of creatinine (D/P creatinine) and ultrafiltration volume, (B) 4- to 0-hour dialysate glucose ratio (D/D0 glucose) and ultrafiltration volume, and (C) 4-hour D/P creatinine and 4-hour D/D0 glucose. The results were obtained from 10,142 individuals who underwent a peritoneal equilibration test with 2.5% dextrose within 6 months of start of treatment with peritoneal dialysis. Rajnish Mehrotra et al. CJASN 2015;10:1990-2001 ©2015 by American Society of Nephrology